These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24903192)
1. Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in cervical artery dissection: a meta-analysis. Luo H; Liu B; Hu J; Wang X; Zhan S; Kong W Cerebrovasc Dis; 2014; 37(5):313-22. PubMed ID: 24903192 [TBL] [Abstract][Full Text] [Related]
2. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345 [TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755 [TBL] [Abstract][Full Text] [Related]
4. The role of methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for coronary artery disease: a cross-sectional study in the Sidoarjo Regional General Hospital. Sugijo H; Sargowo D; Widjajanto E; Romdoni R Pan Afr Med J; 2022; 41():212. PubMed ID: 35721657 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients. Jeon SB; Kang DW; Kim JS; Kwon SU Neurology; 2014 Aug; 83(8):695-701. PubMed ID: 25031284 [TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842 [TBL] [Abstract][Full Text] [Related]
7. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Nakai K; Itoh C; Nakai K; Habano W; Gurwitz D Am J Cardiovasc Drugs; 2001; 1(5):353-61. PubMed ID: 14728017 [TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients. Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756 [TBL] [Abstract][Full Text] [Related]
9. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes. Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656 [TBL] [Abstract][Full Text] [Related]
10. Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients. Abd-Elmawla MA; Rizk SM; Youssry I; Shaheen AA PLoS One; 2016; 11(5):e0155070. PubMed ID: 27187171 [TBL] [Abstract][Full Text] [Related]
11. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Huh HJ; Chi HS; Shim EH; Jang S; Park CJ Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452 [TBL] [Abstract][Full Text] [Related]
12. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151 [TBL] [Abstract][Full Text] [Related]
13. Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Alam MA; Husain SA; Narang R; Chauhan SS; Kabra M; Vasisht S Mol Cell Biochem; 2008 Mar; 310(1-2):111-7. PubMed ID: 18074111 [TBL] [Abstract][Full Text] [Related]
14. Predicting Hyperhomocysteinemia by Methylenetetrahydrofolate Reductase C677T Polymorphism in Chinese Patients With Hypertension. Wang Y; Xu X; Huo Y; Liu D; Cui Y; Liu Z; Zhao Z; Xu X; Liu L; Li X; Jiang S Clin Appl Thromb Hemost; 2015 Oct; 21(7):661-6. PubMed ID: 24459043 [TBL] [Abstract][Full Text] [Related]
15. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis. Pu D; Shen Y; Wu J Autism Res; 2013 Oct; 6(5):384-92. PubMed ID: 23653228 [TBL] [Abstract][Full Text] [Related]
16. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344 [TBL] [Abstract][Full Text] [Related]
17. A prospective cohort study of MTHFR C677T gene polymorphism and its influence on the therapeutic effect of homocysteine in stroke patients with hyperhomocysteinemia. Du X; Xiao L; Sun R; Li K; Liang L; Song L; Liu Z BMC Neurol; 2020 Apr; 20(1):128. PubMed ID: 32278343 [TBL] [Abstract][Full Text] [Related]
18. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690 [TBL] [Abstract][Full Text] [Related]
19. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis. Khandanpour N; Willis G; Meyer FJ; Armon MP; Loke YK; Wright AJ; Finglas PM; Jennings BA J Vasc Surg; 2009 Mar; 49(3):711-8. PubMed ID: 19157768 [TBL] [Abstract][Full Text] [Related]